dc.contributor.author |
Altun, Yaşar |
|
dc.contributor.author |
Yaşar, Erdoğan |
|
dc.date.accessioned |
2025-07-07T11:55:26Z |
|
dc.date.available |
2025-07-07T11:55:26Z |
|
dc.date.issued |
2020 |
|
dc.identifier.issn |
0019-1442 |
|
dc.identifier.uri |
http://dspace.adiyaman.edu.tr:8080/xmlui/handle/20.500.12414/6451 |
|
dc.description.abstract |
Aim - To evaluate P-wave dispersion before and after antiepileptic drug (AED) treatment as well as to investigate the risk of ventricular repolarization using the Tpeak-Tend (Tp-e) interval and Tp-e/QT ratio in patients with epileptic disorder.
Methods - A total of 63 patients receiving AED therapy and 35 healthy adults were included. ECG recordings were obtained before and 3 months after anti-epileptic treatment among patients with epilepsy. For both groups, Tp-e and Tp-e/QT ratio were measured using a 12-lead ECG device.
Results - Tp-e interval, Tpe/QT and Tp-e/QTc ratios were found to be higher in the patient group than in the control group (p<0.05, for all), while QTmax ratio was significantly lower in the patient group. After 3 months of AED therapy, significant increases in QT max, QTc max, QTcd, Tp-e, Tp-e/QT, and Tp-e/QTc were found among the patients (p<0.05). When the arrhythmic effects of the drugs before and after treatment were compared, especially in the valproic acid group, there were significant increases in Tp-e interval, Tp-e/QT and Tp-e/QTc values after three months of treatment (p<0.05). Carbamazepine and levetiracetam groups were not statistically significant in terms of pre- and post-treatment values.
Conclusions - It was concluded that an arrhythmogenic environment may be associated with the disease, and patients who received AED monotherapy may need to be followed up more closely for arrhythmia. |
tr |
dc.language.iso |
en |
tr |
dc.publisher |
LITERATURA MEDICA |
tr |
dc.subject |
epilepsy |
tr |
dc.subject |
ECG |
tr |
dc.subject |
arrhythmia |
tr |
dc.subject |
Tp-e interval |
tr |
dc.subject |
Tp-e/QT ratio |
tr |
dc.title |
EFFECTS OF VALPROATE, CARBAMAZEPINE AND LEVETIRACETAM ON TP-E INTERVAL, TP-E/QT AND TP-E/QTC RATIO |
tr |
dc.type |
Article |
tr |
dc.contributor.authorID |
0000-0001-7013-0618 |
tr |
dc.contributor.authorID |
0000-0001-5882-3534 |
tr |
dc.contributor.department |
Adiyaman Univ, Dept Neurol, Med Fac, |
tr |
dc.contributor.department |
Adiyaman Univ, Med Fac, Dept Cardiol |
tr |
dc.identifier.endpage |
127 |
tr |
dc.identifier.issue |
3-4 |
tr |
dc.identifier.startpage |
121 |
tr |
dc.identifier.volume |
73 |
tr |
dc.source.title |
IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE |
tr |